Header Logo

Connection

Waasila Jassat to South Africa

Back to Details
This is a "connection" page, showing publications Waasila Jassat has written about South Africa.
Waasila Jassat
Connection Strength
1,706
South Africa
  1. Actor sensemaking and its role in implementation of the decentralized drug-resistant tuberculosis policy in South Africa. Health Policy Plan. 2025 Feb 06; 40(2):183-193.
    View in: PubMed
    Score: 0,097
  2. Trends in COVID-19 admissions and deaths among people living with HIV in South Africa: analysis of national surveillance data. Lancet HIV. 2024 Feb; 11(2):e96-e105.
    View in: PubMed
    Score: 0,090
  3. Using generalized structured additive regression models to determine factors associated with and clusters for COVID-19 hospital deaths in South Africa. BMC Public Health. 2023 05 05; 23(1):830.
    View in: PubMed
    Score: 0,085
  4. Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa. Clin Infect Dis. 2023 04 17; 76(8):1468-1475.
    View in: PubMed
    Score: 0,085
  5. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023 Mar; 128:102-111.
    View in: PubMed
    Score: 0,083
  6. Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study. Lancet Glob Health. 2022 09; 10(9):e1247-e1256.
    View in: PubMed
    Score: 0,082
  7. Undiagnosed comorbidities among individuals hospitalised with COVID-19 in South African public hospitals. S Afr Med J. 2022 08 30; 112(9):747-752.
    View in: PubMed
    Score: 0,082
  8. SARS-CoV-2 cases reported from long-term residential facilities (care homes) in South Africa: a retrospective cohort study. BMC Public Health. 2022 May 24; 22(1):1035.
    View in: PubMed
    Score: 0,080
  9. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa. Int J Infect Dis. 2022 Mar; 116:38-42.
    View in: PubMed
    Score: 0,078
  10. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study. Lancet HIV. 2021 09; 8(9):e554-e567.
    View in: PubMed
    Score: 0,076
  11. Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study. Lancet Glob Health. 2021 09; 9(9):e1216-e1225.
    View in: PubMed
    Score: 0,075
  12. A call to action: Temporal trends of COVID-19 deaths in the South African Muslim community. S Afr Med J. 2021 06 15; 111(8):692-694.
    View in: PubMed
    Score: 0,075
  13. Rodent control in urban communities in Johannesburg, South Africa: from research to action. Int J Environ Health Res. 2013 Dec; 23(6):474-83.
    View in: PubMed
    Score: 0,042
  14. Acute mental health care according to recent mental health legislation Part II. Activity-based costing. Afr J Psychiatry (Johannesbg). 2011 Mar; 14(1):23-9.
    View in: PubMed
    Score: 0,037
  15. Organisation of care for people receiving drug-resistant tuberculosis treatment in South Africa: a mixed methods study. BMJ Open. 2023 11 17; 13(11):e067121.
    View in: PubMed
    Score: 0,022
  16. Estimating the time-varying reproduction number for COVID-19 in South Africa during the first four waves using multiple measures of incidence for public and private sectors across four waves. PLoS One. 2023; 18(9):e0287026.
    View in: PubMed
    Score: 0,022
  17. COVID-19 in-hospital mortality during the first two pandemic waves, at Helen Joseph Hospital, South Africa. Pan Afr Med J. 2023; 45:5.
    View in: PubMed
    Score: 0,021
  18. Changing Epidemiology of COVID-19 in Children and Adolescents Over Four Successive Epidemic Waves in South Africa, 2020-2022. J Pediatric Infect Dis Soc. 2023 Apr 18; 12(3):128-134.
    View in: PubMed
    Score: 0,021
  19. Sustained Low Incidence of Severe and Fatal COVID-19 Following Widespread Infection Induced Immunity after the Omicron (BA.1) Dominant in Gauteng, South Africa: An Observational Study. Viruses. 2023 02 21; 15(3).
    View in: PubMed
    Score: 0,021
  20. The role of emergent champions in policy implementation for decentralised drug-resistant tuberculosis care in South Africa. BMJ Glob Health. 2022 12; 7(12).
    View in: PubMed
    Score: 0,021
  21. Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa. Int J Infect Dis. 2023 Feb; 127:63-68.
    View in: PubMed
    Score: 0,021
  22. Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa. Nat Commun. 2022 10 04; 13(1):5860.
    View in: PubMed
    Score: 0,021
  23. Methods for early characterisation of the severity and dynamics of SARS-CoV-2 variants: a population-based time series analysis in South Africa. Lancet Microbe. 2022 10; 3(10):e753-e761.
    View in: PubMed
    Score: 0,020
  24. Clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa. Lancet. 2022 07 09; 400(10346):93-96.
    View in: PubMed
    Score: 0,020
  25. Leveraging epidemiology as a decision support tool during the COVID-19 epidemic in South Africa. S Afr Med J. 2022 05 31; 112(5b):361-365.
    View in: PubMed
    Score: 0,020
  26. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa. Trop Med Int Health. 2022 Jun; 27(6):564-573.
    View in: PubMed
    Score: 0,020
  27. Disease Severity and Comorbidities among Healthcare Worker COVID-19 Admissions in South Africa: A Retrospective Analysis. Int J Environ Res Public Health. 2022 05 02; 19(9).
    View in: PubMed
    Score: 0,020
  28. SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa. Emerg Infect Dis. 2022 May; 28(5):1055-1058.
    View in: PubMed
    Score: 0,020
  29. Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study. Lancet. 2022 03 19; 399(10330):1141-1153.
    View in: PubMed
    Score: 0,020
  30. Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections - a survival analysis. Int J Infect Dis. 2022 May; 118:150-154.
    View in: PubMed
    Score: 0,020
  31. Population Immunity and Covid-19 Severity with Omicron Variant in South Africa. N Engl J Med. 2022 04 07; 386(14):1314-1326.
    View in: PubMed
    Score: 0,020
  32. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study. Lancet Child Adolesc Health. 2022 05; 6(5):294-302.
    View in: PubMed
    Score: 0,020
  33. Guiding equitable prioritisation of COVID-19 vaccine distribution and strategic deployment in South Africa to enhance effectiveness and access to vulnerable communities and prevent waste. S Afr Med J. 2022 02 01; 112(2):13501.
    View in: PubMed
    Score: 0,020
  34. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022 01 29; 399(10323):437-446.
    View in: PubMed
    Score: 0,020
  35. Epidemiology of SARS-CoV-2 infection and SARS-CoV-2 positive hospital admissions among children in South Africa. Influenza Other Respir Viruses. 2022 01; 16(1):34-47.
    View in: PubMed
    Score: 0,019
  36. Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020. S Afr Med J. 2021 11 05; 111(11):1078-1083.
    View in: PubMed
    Score: 0,019
  37. Understanding the differential impacts of COVID-19 among hospitalised patients in South Africa for equitable response. S Afr Med J. 2021 11 05; 111(11):1084-1091.
    View in: PubMed
    Score: 0,019
  38. SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020-March 2021. Emerg Infect Dis. 2021 12; 27(12):3020-3029.
    View in: PubMed
    Score: 0,019
  39. A call to action: Temporal trends of COVID-19 deaths in the South African Muslim community. S Afr Med J. 2021 07 14; 111(9):13348.
    View in: PubMed
    Score: 0,019
  40. 'We had to manage what we had on hand, in whatever way we could': adaptive responses in policy for decentralized drug-resistant tuberculosis care in South Africa. Health Policy Plan. 2021 Apr 21; 36(3):249-259.
    View in: PubMed
    Score: 0,019
  41. COVID-19 in long-term care facilities in South Africa: No time for complacency. S Afr Med J. 2020 09 04; 110(10):962-963.
    View in: PubMed
    Score: 0,018
  42. The COVID-19 crisis in South Africa: Protecting the vulnerable. S Afr Med J. 2020 07 08; 110(9):825-826.
    View in: PubMed
    Score: 0,018
  43. Drug-resistant tuberculosis patient care journeys in South Africa: a pilot study using routine laboratory data. Int J Tuberc Lung Dis. 2020 01 01; 24(1):83-91.
    View in: PubMed
    Score: 0,017
  44. Pregnancy outcomes and birth defects from an antiretroviral drug safety study of women in South Africa and Zambia. AIDS. 2014 Sep 24; 28(15):2259-68.
    View in: PubMed
    Score: 0,012
  45. Comparing a paper based monitoring and evaluation system to a mHealth system to support the national community health worker programme, South Africa: an evaluation. BMC Med Inform Decis Mak. 2014 Aug 09; 14:69.
    View in: PubMed
    Score: 0,012
  46. Impact of supplemental immunisation activity (SIA) campaigns on health systems: findings from South Africa. J Epidemiol Community Health. 2013 Nov 01; 67(11):947-52.
    View in: PubMed
    Score: 0,011
  47. Supplementary immunization activities (SIAs) in South Africa: comprehensive economic evaluation of an integrated child health delivery platform. Glob Health Action. 2013 Mar 01; 6:1-9.
    View in: PubMed
    Score: 0,011
  48. Phased implementation of screening for cryptococcal disease in South Africa. S Afr Med J. 2012 Oct 08; 102(12):914-7.
    View in: PubMed
    Score: 0,010
  49. Measles control in Sub-Saharan Africa: South Africa as a case study. Vaccine. 2012 Feb 21; 30(9):1594-600.
    View in: PubMed
    Score: 0,010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.